Moderna
MRNA
$123.64
Share price
-0.55%
Change (1 day)
-71.26%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Market capitalization of Moderna (MRNA)
Market cap: $50.12 Billion
As of September 2022 Moderna has a market cap of $50.12 Billion. This makes Moderna the world's 281th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Moderna from 2018 to 2022
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2022 | $50.12 B | -51.32% |
| 2021 | $102.97 B | 149.1% |
| 2020 | $41.33 B | 528.01% |
| 2019 | $6.58 B | 31.11% |
| 2018 | $5.02 B |
End of Day market cap according to different sources
On Sep 24th, 2022 the market cap of Moderna was reported to be:
$48.36 Billion
$48.36 Billion
$48.36 Billion
$49.17 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $438.33 B | 774.40% | 🇺🇸 USA |
 Novartis NVS | $166.30 B | 231.75% | 🇨🇭 Switzerland |
 Merck MRK | $219.83 B | 338.54% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $0.25 B | -99.50% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | $2.97 B | -94.06% | 🇺🇸 USA |
 Athersys ATHX | $0.38 B | -99.24% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $24.01 B | -52.10% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $3.23 B | -93.55% | 🇺🇸 USA |